This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.
Ministry of Health updated temporary guidelines for the treatment of COVID-19
The Ministry of Health has presented the 13th version of the recommendations for the treatment of coronavirus. Additions were made to the document for groups of patients who, on a priority basis, are shown therapy with the help of new antiviral drugs.
As follows from the next version of the recommendations published on the website of the Ministry of Health, patients from high-risk groups for the severe course of coronavirus infection should, as a matter of priority, receive treatment with drugs based on monoclonal antibodies - antibodies isolated from the blood plasma of COVID-19 patients and purified from unnecessary proteins. Treatment with such drugs is effective in the first week after infection and allows you to form immunity to the virus within a few hours after ingestion.
The priority groups now include: pregnant women, postpartum women with both types of diabetes, diagnosed with cystic fibrosis, chronic kidney disease, severe bronchial asthma, obesity, heart failure (for patients 65+) and chronic obstructive pulmonary disease, and some other types of diseases. The full list can be found on the website of the Ministry of Health.